UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Shares
Symbol
UTMD on Nasdaq
Shares outstanding
3,203,885
Price per share
$55.96
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
2,170,126
Total reported value
$136,631,381
% of total 13F portfolios
0%
Share change
+11,142
Value change
+$876,895
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
115
Price from insider filings
$62.75
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BRANDES INVESTMENT PARTNERS, LP 10% +25% $20,105,529 +$3,720,987 333,204 +23% BRANDES INVESTMENT PARTNERS, LP 31 Aug 2025
RENAISSANCE TECHNOLOGIES LLC 6.7% $12,543,095 230,614 Renaissance Technologies LLC 30 Sep 2024
DIMENSIONAL FUND ADVISORS LP 6.1% $10,366,965 197,466 Dimensional Fund Advisors LP 30 Jun 2025
BlackRock, Inc. 5.3% +6.6% $9,065,910 +$213,675 172,684 +2.4% BlackRock, Inc. 30 Jun 2025
FMR LLC 2.7% $5,023,460 92,360 FMR LLC 31 Dec 2024
As of 30 Sep 2025, UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 115 institutional shareholders filing 13F forms. They hold 2,170,126 shares. of 3,203,885 outstanding shares (68%) .

Top 25 institutional shareholders own 60% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BRANDES INVESTMENT PARTNERS, LP 11% 337,930 +25% 0.17% $21,279,452
RENAISSANCE TECHNOLOGIES LLC 6.3% 200,914 -5.8% 0.02% $12,651,555
DIMENSIONAL FUND ADVISORS LP 6.2% 200,032 +1.3% 0% $12,595,909
BlackRock, Inc. 5.6% 179,822 +0.17% 0% $11,323,421
VANGUARD GROUP INC 5.5% 175,627 -0.83% 0% $11,059,232
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 3.4% 109,001 -2.6% 0.02% $6,863,793
Minerva Advisors LLC 2.9% 93,058 0% 3.7% $5,859,862
GEODE CAPITAL MANAGEMENT, LLC 2.8% 89,961 -22% 0% $5,666,274
STATE STREET CORP 2.2% 70,263 +0.2% 0% $4,445,608
RICE HALL JAMES & ASSOCIATES, LLC 1.9% 61,431 -10% 0.21% $3,868,279
MORGAN STANLEY 1.8% 57,294 -1.5% 0% $3,607,882
Huber Capital Management LLC 1.5% 47,852 -14% 0.48% $3,013,241
Bank of New York Mellon Corp 1.4% 45,528 -7.3% 0% $2,866,874
ISTHMUS PARTNERS, LLC 1.2% 38,283 +13% 0.54% $2,410,681
NORTHERN TRUST CORP 0.98% 31,397 -6.1% 0% $1,977,070
Cardinal Capital Management 0.76% 24,377 +7% 0.21% $1,542,440
Quantinno Capital Management LP 0.72% 22,956 +115% 0% $1,445,539
BARD ASSOCIATES INC 0.65% 20,771 +3.8% 0.35% $1,313,776
MILLENNIUM MANAGEMENT LLC 0.64% 20,556 -31% 0% $1,294,411
EVERETT HARRIS & CO /CA/ 0.54% 17,193 -1.6% 0.01% $1,082,643
PRICE T ROWE ASSOCIATES INC /MD/ 0.5% 16,164 +0.29% 0% $1,019,000
AQR CAPITAL MANAGEMENT LLC 0.48% 15,406 +79% 0% $970,117
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 0.45% 14,566 +147% 0.01% $917,221
Qube Research & Technologies Ltd 0.42% 13,488 +7.6% 0% $849,339
AMERIPRISE FINANCIAL INC 0.42% 13,400 -25% 0% $843,798

Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 919 $51,427 -$8,898 5,595.95% 4
2025 Q3 2,170,126 $136,631,381 +$876,895 6,297% 115
2025 Q2 2,154,610 $122,645,130 -$4,286,491 5,692% 109
2025 Q1 2,232,321 $125,139,210 -$3,530,604 5,604% 107
2024 Q4 2,296,843 $141,225,482 -$8,017,331 6,147% 112
2024 Q3 2,408,468 $161,160,659 +$1,503,697 6,691% 109
2024 Q2 2,402,350 $160,537,235 -$6,987,297 6,681% 100
2024 Q1 2,489,842 $177,080,276 -$8,583,956 7,111% 99
2023 Q4 3,279 $276,157 +$4,211 8,421.99% 1
2023 Q3 2,572,558 $221,268,261 +$1,876,431 8,600% 90
2023 Q2 2,546,497 $237,442,024 +$487,120 9,320% 88
2023 Q1 2,542,650 $240,992,336 +$8,526,555 9,477% 85
2022 Q4 2,546,020 $255,957,647 +$1,190,438 10,053% 80
2022 Q3 2,535,307 $216,305,461 -$31,278,946 8,530.91% 74
2022 Q2 2,549,444 $219,019,775 -$1,106,912 8,590.3% 72
2022 Q1 2,567,240 $230,687,477 -$2,180,650 8,986.03% 81
2021 Q4 2,514,005 $251,482,000 -$298,301 10,000% 75
2021 Q3 2,601,535 $241,486,518 +$234,289 9,283.24% 71
2021 Q2 2,599,350 $221,067,972 -$2,718,230 8,504.02% 67
2021 Q1 2,631,848 $227,937,195 +$450,172 8,660.09% 77
2020 Q4 2,431,582 $204,998,874 -$3,583,382 8,429.88% 74
2020 Q3 2,476,759 $197,896,100 -$2,808,417 7,987.02% 80
2020 Q2 2,681,245 $237,637,790 +$3,955,744 8,862.38% 90
2020 Q1 2,627,773 $247,142,933 -$14,078,947 9,404.66% 87
2019 Q4 2,771,659 $299,081,615 -$7,825,682 10,789.69% 94
2019 Q3 2,845,020 $272,682,253 +$7,805,018 9,583.87% 92
2019 Q2 2,694,661 $257,742,413 +$3,431,656 9,570% 94
2019 Q1 2,667,156 $235,377,738 +$167,473 8,824.96% 87
2018 Q4 2,678,201 $222,500,243 -$3,345,746 8,307.93% 82
2018 Q3 2,788,159 $262,628,591 +$18,723,998 9,419.99% 88
2018 Q2 2,586,006 $284,760,113 +$1,054,674 11,014.8% 90
2018 Q1 2,585,315 $255,558,283 +$9,117,799 9,885.15% 77
2017 Q4 2,497,010 $203,057,932 +$2,191,027 8,139.7% 77
2017 Q3 2,462,541 $181,161,037 +$282,499 7,355.02% 72
2017 Q2 2,477,220 $179,326,060 +$4,870,827 7,239.97% 74
2017 Q1 2,420,703 $150,804,030 +$6,332,177 6,230.02% 75
2016 Q4 2,477,886 $180,211,111 -$462,985 7,274.8% 75
2016 Q3 2,500,148 $149,501,799 -$1,272,108 5,979.97% 78
2016 Q2 2,519,797 $158,744,245 -$2,050,779 6,300.16% 75
2016 Q1 2,555,094 $159,803,564 +$3,077,124 6,253.94% 68
2015 Q4 2,526,524 $147,852,615 +$2,328,859 5,853.96% 64
2015 Q3 2,466,259 $133,025,937 -$504,880 5,387.16% 58
2015 Q2 2,422,586 $144,407,790 +$3,675,329 5,963.01% 62
2015 Q1 2,413,277 $144,432,777 -$2,251,115 5,985.93% 58
2014 Q4 2,473,128 $148,478,172 -$16,218 6,004.99% 59
2014 Q3 2,205,551 $107,547,653 -$11,678,364 4,876.1% 60
2014 Q2 2,427,382 $124,860,931 +$1,473,686 5,143.88% 60
2014 Q1 2,397,038 $138,529,175 +$3,535,355 5,783.04% 58